Assisted Reproduction
Fertility preservation is possible after surgery/chemotherapy for malignant germ cell tumors
Published in Women's Health Weekly, September 7th, 2006
Scientists at Kurume University report, "The aim of this study was to investigate whether fertility preservation influences the clinical outcome in patients with malignant germ cell tumors of the ovary (MGCTO)."
S. Nishio and colleagues described their investigation: "A case study analysis was performed on patients with MGCTO treated at Kurume University Hospital between 1986 and 2004. Thirty-five patients were included in the study, 14 with immature teratoma, 11 with dysgerminoma, eight with endodermal sinus tumor, and two with mixed germ cell...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Ki-67 expression found in breast fluid may be biomarker for early cancer detection - Irritable Bowel Syndrome
Gender influences sensitivity to rectosigmoid distension in irritable bowel syndrome - Stroke
Healthy behaviors decrease risk of ischemic stroke in women - Type 2 Diabetes
Dairy intake may lower risk of type 2 diabetes in older to middle-aged minority women - Type 2 Diabetes
Ethnicity plays major role in women as risk factor for developing type 2 diabetes - Breast Cancer
A plant that gave ancient Britons and Celts blue war paint is source of an anti-cancer compound - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
